Posted on 12/9/20
HOOKIPA Pharma Proposes Public Offering of Common Stock and Preferred Stock
NEW YORK and VIENNA, Austria, Dec. 08, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on . . .
Posted on 12/9/20
Thoma Bravo Acquires AxiomSL
Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, today announced the completion of its acquisition of AxiomSL
Posted on 12/9/20
ADMA Biologics Enters Into $100 Million Credit Facility
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 09, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing . . .
Posted on 12/9/20
Pfizer's Coronavirus Vaccine Is 52.4% Effective After First Dose
On Monday morning, the FDA published briefing documents for an upcoming meeting of a panel of independent medical experts who will weigh in on data from . . .
Posted on 12/9/20
iBio: Another Vaccine Effort Unlikely To Materialize
SummaryiBio (IBIO) is a Texas-based company whose stock is up 496% year to date on investor optimism about its COVID-19 vaccine efforts.IBIO claims to have been . . .
Posted on 12/8/20
Neurotrope Completes Independent Spin-off of Neurotrope Bioscience and is Renamed Synaptogenix
Synaptogenix, Inc. (OTC: SNPX), formerly Neurotrope Bioscience, Inc., today announced the successful spin-off of substantially all of the legacy assets and liabilities of Neurotrope, Inc. into . . .
Posted on 12/8/20
Cantel Medical Reports Financial Results for its First Quarter Fiscal Year 2021
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2020.First quarter 2021 net sales were $297.0M, up 15.5% compared . . .
Posted on 12/8/20
Trinity Life Sciences Acquires BluePrint Research Group
Trinity Life Sciences, the leading commercial partner to the life sciences industry, announced the acquisition of New Jersey-based BluePrint Research Group. The acquisition positions Trinity
Posted on 12/8/20
With Slow Health Benefit Cost Growth In 2020, Employers Plan To Invest In More Support For Employees, Says Mercer
Total health benefit cost rose 3.4% on average in 2020 (Fig. 1), reaching $13,674 per employee among all US employer health plan sponsors with 50 or . . .
Posted on 12/8/20
Bristol-Myers Squibb Contingent Value Rights: Final Inspection Is Happening
SummaryThe contingent value right issued to Celgene shareholders after the Bristol-Myers acquisitions are dependent on approval of Liso-cell and Ide-cell.For Liso-cell to be approved the FDA . . .
Posted on 12/8/20
Agile Therapeutics: Managing A Position Ahead Of Twirla's Launch
SummaryAgile Therapeutics is preparing to launch their first FDA approved product, Twirla. If all goes well, Twirla could quickly establish a foothold in a $4.1B addressable . . .
Posted on 12/8/20
NanoVibronix Closes $6M Private Placement Priced At-the-Market
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today . . .
Posted on 12/7/20
Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma (Nasdaq: RPRX), BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and Athyrium Capital Management, . . .
Posted on 12/7/20
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), Royalty Pharma plc (Nasdaq: RPRX) and Athyrium Capital . . .
Posted on 12/7/20
This COVID Vaccine Stock Has Been the Biggest Millionaire-Maker by Far
It's not surprising in the least that the stocks of several companies in the race to develop coronavirus vaccines have been sizzling hot so far this . . .
Posted on 12/7/20
Buffett Buys Merck - And You Should, Too
SummaryMerck owns one of the best drugs in the world, Keytruda.The company has a solid growth outlook going forward.An inexpensive valuation and a solid dividend yield . . .
Posted on 12/7/20
Pfizer: Coronavirus Vaccine Playing Out, Still Inexpensive And Offering A High Yield
SummaryPfizer's vaccine for COVID looks promising and should boost revenues substantially.The company is trading at an inexpensive valuation and offers an above-average dividend yield.For those seeking . . .
Posted on 12/7/20
Is Pfizer a Great Dividend Stock?
There's a lot of excitement today surrounding Pfizer (NYSE:PFE) and the COVID-19 vaccine that it's working on with BioNTech. The vaccine is more than 90% effective . . .
Posted on 12/6/20
Trinity Rehab Supports New Jersey 101.5’s Feel Better Bears Campaign For the Third Year in a Row
Trinity Rehab, an all-inclusive physical therapy and rehabilitation center providing comprehensive treatment for patients of all ages, walks of life and fitness levels, joins New Jersey . . .
Posted on 12/6/20
Trinity Rehab in Clifton to Host Open House and Ribbon Cutting on Wednesday December 9th
Trinity Rehab, an all-inclusive physical therapy and rehabilitation center providing comprehensive treatment for patients of all ages, walks of life and fitness levels, will host a . . .
Posted on 12/4/20
Merck Just Sold Off Its Moderna Shares for a Huge Gain. Should You?
Practically everything is going right for Moderna (NASDAQ:MRNA) these days. The biotech announced surprisingly positive efficacy results for its COVID-19 vaccine candidate mRNA-1273, and it has . . .
Posted on 12/4/20
Pfizer to Ship Half as Many Coronavirus Vaccine Doses as Originally Planned in Initial Phase
The supply of the coronavirus vaccine developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) will be significantly lower than first anticipated -- at least in the initial . . .
Posted on 12/4/20
Is Teladoc Stock a Buy?
Telehealth provider Teladoc Health (NYSE:TDOC) has experienced revolutionary changes to its business due to the COVID-19 pandemic. Before the spread of the virus, only 11% of . . .
Posted on 12/4/20
SWORD Health Recognized as a Top 3 Wellness Service on Inc.’s Best in Business List
NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- SWORD Health has been named to Inc.’s inaugural Best in Business list in the Wellness Services category. Inc. . . .
Posted on 12/3/20
dancker’s New Logistical Facility Will Handle PPE for Healthcare Clients
Integrated interior solutions firm dancker has established a new logistical facility to support their healthcare clients’ COVID-19 planning and specifically help one of New Jersey’s largest . . .
New York
